Stock Events

Stock Events

Senseonics 

0
433
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

6AugExpected
Q1 2026
Next
-0.61
-0.58
-0.56
-0.54
Expected EPS
-0.537475589
Actual EPS
N/A

Financials

-196.47%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
30.47MRevenue
-59.87MNet Income

Analyst Ratings

10.12Average Price Target
The highest estimate is 13.66.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
67%
Hold
33%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 6L6.MU. It's not an investment recommendation.
Tesla
67
TSLA
Apple
65
AAPL
Palantir Technologies
59
PLTR
Amazon
57
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Dexcom
DXCM
Mkt Cap28.93B
Dexcom produces continuous glucose monitoring systems for diabetes management, directly competing with Senseonics' Eversense CGM system.
Abbott Laboratories
ABT
Mkt Cap163.61B
Abbott Laboratories offers the FreeStyle Libre, a flash glucose monitoring system, competing in the glucose monitoring space.
Tandem Diabetes Care
TNDM
Mkt Cap1.06B
Tandem Diabetes Care manufactures insulin pumps and integrated diabetes management systems, competing in the broader diabetes management market.
Insulet
PODD
Mkt Cap11.17B
Insulet Corporation develops the Omnipod, an insulin management system, which competes with diabetes management solutions like Senseonics'.
Medtronic
MDT
Mkt Cap107.36B
Medtronic offers the Guardian Sensor 3 CGM and insulin pumps, providing integrated diabetes management solutions.
Mirum Pharmaceuticals
MIRM
Mkt Cap7.45B
Mirum Pharmaceuticals, though more focused on liver diseases, has interests in metabolic disorders, potentially overlapping with diabetes management.
Novo Nordisk
NVO
Mkt Cap218.94B
Novo Nordisk specializes in diabetes care with insulin and GLP-1 receptor agonists, indirectly competing in diabetes management.
Sanofi
SNY
Mkt Cap104.13B
Sanofi produces insulin and other diabetes medications, competing in the broader market for diabetes management.
Merck
MRK
Mkt Cap305.12B
Merck & Co., with its diabetes medication portfolio, including Glucophage, competes in the pharmaceutical management of diabetes.
Bristol-Myers Squibb
BMY
Mkt Cap117.58B
Bristol-Myers Squibb, through its metabolic disorders treatment portfolio, indirectly competes in the diabetes management space.

About

Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
Show more...
CEO
Dr. Timothy T. Goodnow Ph.D.
Employees
130
Country
United States
ISIN
US81727U1051

Listings

MU
DE
6L60.MU
F
DE
6L60.F
MU
DE
6L6.MU
STU
DE
6L60.STU

0 Comments

Share your thoughts

FAQ

What is Senseonics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Senseonics stocks are traded under the ticker 6L6.MU.
When is the next Senseonics earnings date?▼
Senseonics is going to release the next earnings report on August 06, 2026.
What were Senseonics earnings last quarter?▼
6L6.MU earnings for the last quarter are -0.61 EUR per share, whereas the estimation was -0.58 EUR resulting in a -3.57% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Senseonics revenue for the last year?▼
Senseonics revenue for the last year amounts to 30.47M EUR.
What is Senseonics net income for the last year?▼
6L6.MU net income for the last year is -59.87M EUR.
How many employees does Senseonics have?▼
As of July 22, 2026, the company has 130 employees.
In which sector is Senseonics located?▼
Senseonics operates in the Other sector.
When did Senseonics complete a stock split?▼
The last stock split for Senseonics was on October 20, 2025 with a ratio of 1:20.
Where is Senseonics headquartered?▼
Senseonics is headquartered in Germantown, United States.